NASDAQ
No price data available for this timeframe.
Bioventus Inc. (BVS) has a free cash flow growth of -77.64% as of Friday, May 29, 2026. This represents a 606.76% decrease compared to its 12-month average of 15.32%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.